Anuja Java, MD

Anuja Java, MD

Associate Professor of Medicine, Division of Nephrology

Additional Titles

  • Director, Kidney Transplant Clinic at Veterans Affairs St. Louis Health Care System

Location

Patients seen at

Map of location

Center for Advanced Medicine

Patients seen at

Map of location

Barnes-Jewish Dialysis Center

Mailing Address

Division of Nephrology

  • Mailing Address: 660 S. Euclid Ave., CB 8126
    St. Louis, MO 63110

In the News

Education

  • Fellowship in Transplant Nephrology: Washington University School of Medicine in St. Louis, St. Louis, MO (2012)
  • Residency in Internal Medicine: Orlando Regional Medical Center, Orlando, FL (2010)
  • Externship Internal Medicine: St. John’s Regional Medical Center and Freeman Health System, Joplin, MO (2004)
  • Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.): Government Medical College, Nagpur, India (2002)

Board Certifications

  • ABIM Board Certified in Nephrology, 2008
  • ABIM Board Certified in Internal Medicine, 2005

Recognition

2025
Invited to join 2025 Board of Directors, Mid-America Transplant Foundation, St. Louis, MO

2024
Nominated by WUSM Department of Medicine to attend the AAMC Mid-career Women in Medicine Leadership workshop, Santa Ana, New Mexico.

2022
Award of Excellence for significant contributions to the field of kidney disease and the renal community, National Kidney Foundation.

2013
Travel award to attend “Origins of Renal Physiology” workshop for Fellows at the Mount Desert Island Biological Laboratory (MDIBL), Bar Harbor, Maine

2012
Travel award to attend the “AST Fellows Symposium” in Grapevine, Texas

2008
Chief Resident Award; PGY3, Internal Medicine

2007
ACP Clinical Vignette Finalist (Florida Chapter)

2006
Best Primary Care Physician Award; PGY1, Internal Medicine

Clinical Interests

Kidney transplantation, recurrent glomerulonephritis, chronic kidney disease and fluid and electrolyte disorders.

Research Interests

Investigating the role of complement receptors and regulators in the pathogenesis of immune and inflammatory processes in the kidney.

In particular, Dr. Java is interested in defining the functional consequences of genetic mutations identified in complement-mediated kidney diseases such as atypical hemolytic uremic syndrome and C3 glomerulopathy.

Publications

Jalal A, Atari M, Hassanein M, Java A. Thrombotic Microangiopathy and the Kidney. n: StatPearls Publishing. Updated Jan 17, 2025.

Java A, Sparks MA, Kavanagh D. Post-transplant Thrombotic Microangiopathy. J Am Soc Nephrol. May 1;36(5):940-951; 2025.

Java A. Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy. Hematology. American Society of Hematology. Education Program, 2024(1), 200–205. 

Java A, Burwick R, Chang A. Thrombotic Microangiopathies and the Kidney. AKDH. 31:3, 255-264; May 2024.

Urra M, Lyons S, Teodosiu C, Burwick R, Java A. Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies. Kidney International Reports. 2024

Attieh RM, Wanchoo R, Java A. Banff Working Group Defines Pathological Diagnostic Criteria for Thrombotic Microangiopathy in the Renal Allograft. ASN Kidney News. January 2024.

Laue K, Schutlz M, Talbot-Montgomery, Garrick A, Java A, Corbett C, Lammert D, Rogers J, Davis K, Malhotra K, Philipneri, M, Kimbel M, Mustafa R, Hardesty V. Show Me CKDintercept Initiative: A Collective Impact Approach to Improve Population Health in Missouri. MCP:IQ&O. Volume 8, Issue 1, 82-96, 2024.

Merzkani M, Lynn NCW, Flores K, Rajashekar G, Progar K, Delos Santos R, Atkinson JP, Brennan DC, Java A. Thrombotic Microangiopathy after Kidney Transplantation: Insights into Genetic Etiology and Clinical Outcomes. Jan 30;10(4):1152-1162; 2025.

Lokki, A. I., Triebwasser, M., Daly, E., FINNPEC Core Investigator Group, Kurki, M. I., Perola, M., Auro, K., Salmon, J. E., Java, A, Daly, M., Atkinson, J. P., Laivuori, H., & Meri, S. Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia. Genes and immunity; 26, pages 22–26 (2025) 2024.

Java A, Fuller L. Establishing the Future Direction of Clinical Outcomes in C3 Glomerulopathy: Perspectives from a Patient and a Physician. Kidney Med, 7:1, Nov 2024.

Ames EG, Anand PM, Bekheirnia MR, Doshi MD, El Ters M, Freese ME, Gbadegesin RA, GuayWoodford LM, Java A, Ranch D, Rodig NM, Wang X, Thomas CP. Evaluation for genetic disease in kidney transplant candidates: A practice resource. Am J Transplant. Feb; 25(2):237-249, 2025.

Bansal N, Zelnick L, Java A, Nicholas SB, Curtis LM. Perceptions and Experiences of Gender Equity among Women in Academic Nephrology. J Am Soc Nephrol. 2024.

Meena, P, Arellano-Mendez, D, Calice-Silva, V, Bek, Sibel G, Tomacruz A, Isabelle D, Yadla, M, Mohan, K, Bajpai, D, Shankar, M, Java, A, Soki, K, Arce-Amare, F, Luyckx, V, Karam, S. Exploring the Challenges and Limitations in Participation of Women Nephrologists at Conferences: A Pilot Study. CJASN. October 2024.

Nester, CM., Feldman, DL., Burwick, R., Cataland, S., Chaturvedi, S., Cook, HT., Cuker, A., Dixon, BP., Fakhouri, F., Hingorani, SR., Java, A., van de Kar, NCAJ., Kavanagh, D., Leung, N., Licht, C., Noris, M., O’Shaughnessy, MM., Parikh, SV., Peyandi, F., Remuzzi, G., Vivarelli, M. . An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group. Kidney International, 106(3), 326–336; 2024